Diallyl Disulfide Attenuates Ionizing Radiation-Induced Migration and Invasion by Suppressing Nrf2 Signaling in Non–small-Cell Lung Cancer. Issue 3 (2nd August 2021)
- Record Type:
- Journal Article
- Title:
- Diallyl Disulfide Attenuates Ionizing Radiation-Induced Migration and Invasion by Suppressing Nrf2 Signaling in Non–small-Cell Lung Cancer. Issue 3 (2nd August 2021)
- Main Title:
- Diallyl Disulfide Attenuates Ionizing Radiation-Induced Migration and Invasion by Suppressing Nrf2 Signaling in Non–small-Cell Lung Cancer
- Authors:
- Xu, Shuai
Huang, Hefa
Tang, Deping
Xing, Mengjie
Zhao, Qiuyue
Li, Jianping
Si, Jing
Gan, Lu
Mao, Aihong
Zhang, Hong - Abstract:
- Non–small-cell lung cancer (NSCLC) is the leading cause of cancer-associated deaths. Radiotherapy remains the primary treatment method for NSCLC. Despite great advances in radiotherapy techniques and modalities, recurrence and resistance still limit therapeutic success, even low-dose ionizing radiation (IR) can induce the migration and invasion. Diallyl disulfide (DADS), a bioactive component extracted from garlic, exhibits a wide spectrum of biological activities including antitumor effects. However, the effect of DADS on IR-induced migration and invasion remains unclear. The present study reported that IR significantly promoted the migration and invasion of A549 cells. Pretreatment with 40 μM DADS enhanced the radiosensitivity of A549 cells and attenuated IR-induced migration and invasion. In addition, 40 μM DADS inhibited migration-related protein matrix metalloproteinase-2 and 9 (MMP-2/9) expression and suppressed IR-aggravated EMT by the upregulation of the epithelial marker, E-cadherin, and downregulation of the mesenchymal marker, N-cadherin, in A549 cells. Furthermore, DADS was found to inhibit the activation of Nrf2 signaling. Based on our previous results that knockdown of Nrf2 by siRNA suppressed IR-induced migration and invasion in A549 cells, we speculated that DADS attenuated IR-induced migration and invasion by suppressing the activation of Nrf2 signaling in A549 cells.
- Is Part Of:
- Dose-response. Volume 19:Issue 3(2021)
- Journal:
- Dose-response
- Issue:
- Volume 19:Issue 3(2021)
- Issue Display:
- Volume 19, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 19
- Issue:
- 3
- Issue Sort Value:
- 2021-0019-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-08-02
- Subjects:
- diallyl disulfide -- ionizing radiation -- migration -- invasion -- Nrf2 -- non-small-cell lung cancer
Dose-response relationship (Biochemistry) -- Periodicals
Drugs -- Dose-response relationship -- Periodicals
Drugs -- Physiological effect -- Periodicals
Hormesis -- Periodicals
Dose-Response Relationship, Drug -- Periodicals
Dose-response relationship (Biochemistry)
Drugs -- Dose-response relationship
Drugs -- Physiological effect
Periodicals
571.634 - Journal URLs:
- http://journals.sagepub.com/home/dos ↗
http://dos.sagepub.com/ ↗
http://dose-response.metapress.com ↗
http://www.dose-response.com/ ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/614/ ↗
http://www.sagepublications.com/ ↗ - DOI:
- 10.1177/15593258211033114 ↗
- Languages:
- English
- ISSNs:
- 1559-3258
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17234.xml